HTA bodies must take into account ethical, legal, and social issues (ELSI) during their assessments of health technologies.
Health Technology Assessment (HTA)
Economic evaluation in HTA is a comparison of costs and consequences of health technologies.
HTA bodies carry out clinical effectiveness assessments, in which new technologies are compared with the standard of care and other existing treatments.
The way patients are involved in an HTA body depends on the political and cultural context. Patient involvement in HTA should be developed as the result of a partnership between the HTA body and patient representatives, and it should be constantly evolving in response to experience and feedback.
HTA bodies vary from place-to-place and are established in rough correspondence to a health system.
Health Technology Assessment (HTA) processes are varied, but some fundamentals apply.
The International Working Group for for HTA Advancement has developed a set of fifteen key principles for health technology assessment bodies.
In this video, three patient advocates discuss the extent of patient involvement in HTA processes.
After Phase III of clinical studies, all the information on a medicin is collected and organised in a pre-determiend format (a dossier), which is then submitted to the regulatory authorities. The regulatory authorities then decide whether or not a medicine can be prescribed to patients.